NATURE:Eleven clinical trials that will shape medicine in 2026

This collection outlines a series of groundbreaking clinical trials slated to conclude or produce results by 2026, representing a new frontier in the treatment of chronic and infectious diseases. The text is structured as a survey of diverse medical fields, highlighting innovations such as long-acting HIV antibodies, mRNA-based immunotherapy for autoimmune disorders, and precision gene editing to cure rare genetic defects. Key themes include the shift toward targeted therapies that minimize side effects, the discovery of novel biomarkers like inflammation and specific proteins to prevent heart disease, and the development of more durable vaccines for global health crises. Ultimately, the purpose of this source is to showcase how cutting-edge biotechnology is transitioning from experimental research into practical, life-changing solutions for patients with previously intractable conditions.